Navigation Links
Bladder Cancer No Longer a Death Sentence
Date:6/30/2009

SARASOTA, Fla., June 30 /PRNewswire/ -- At 51, Charles Daniels had a lot to live for. A thriving construction business, a precious 11 year old daughter and a happy long-term relationship. When he was diagnosed with bladder cancer, he was determined to beat the odds. According to TMD, a medical tourism corporation, Daniels case is typical - he tried conventional medicine until they had nothing left to offer but a poor prognosis, and then went out of the country for alternative cancer treatment and is cancer free today.

Just before Christmas 2007, Daniels urinated blood. He went right to his primary care doctor, who did an ultrasound and X-rays, which were inconclusive. Suspecting an infection, his doctor gave him antibiotics. Within 24 hours, the blood was no longer visible. But a follow up visit showed microscopic blood in his urine, and he was sent to a urologist. A cytoscopy exam (where a small camera is inserted into the bladder) and intra-venous pyelogram (an X-ray with contrast that provides pictures of the entire urinary system) found bladder cancer. "I was shocked," Daniels said. "I was in perfect health, I felt good, and I thought I just had an infection."

This year, almost 71,000 Americans will be diagnosed with bladder cancer. According to the National Cancer Institute, the survival rate for stage III bladder cancer is 50%; stage IV is rarely survived. Symptoms include blood in the urine and frequent, painful or urgent urination.

Risk factors are smoking, chemical exposure to dyes, rubber and pesticides, chronic infections and parasites. Women undergoing chemotherapy and radiation for cervical cancer also have an increased risk of developing bladder cancer.

Daniels' oncologist recommended surgery to remove the tumor. While his doctor was cautiously optimistic, further testing confirmed the invasive tumor had penetrated the muscle wall. "My doctor wanted to remove my bladder, prostate and surrounding lymph nodes, and create a new bladder from my intestines. He said with this surgery I had a 90% survival rate. I wanted to live, and 90% sounded like a good number."

Daniels expected to wake up after surgery and be cancer free. But his surgeon found that the tumor had grown outside the bladder wall and surrounding lymph nodes tested positive. His survival rate dropped from 90% to 40%. Despite an aggressive chemotherapy program, his next CAT scan revealed three new tumors in his liver. He now was stage IV. At this point, mainstream medicine offered no hope of cure, and his life expectancy dropped to around nine months. The chemotherapy left him feeling exhausted and sick, and he suffered weight and hair loss. Permanent side effects included hearing loss, tingling in his extremities and 'chemo brain'.

Next, Daniels underwent Radio Frequency Ablation (RAF), a guided imagery surgery where a needle like probe transmits microwaves into tumors causing the destruction of tumor cells. The RAF destroyed the tumors, but he was told they would come back - there is no mainstream cure for his cancer.

Daniels then began researching alternative treatments. He sent emails with his medical history to clinics throughout the United States and Mexico. He interviewed doctors and talked to patients. When he asked about success rates, the answers he received ranged from "we'll make you more comfortable" to "complete remission".

Finally, he learned about a fairly new cancer treatment called SonoPhoto Dynamic Therapy (SPDT). This non-invasive treatment uses a non-toxic sensitizing agent along with sound and light to destroy cancer cells. Dr. Antonio Jimenez, medical director of the Hope4Cancer Institute south of San Diego, California in Baja, Mexico, has successfully treated bladder and other cancers with this program. Although this is a natural treatment without side effects, SPDT is considered a mainstream cancer treatment in 25 European countries. SPDT has proven effective against ovarian, prostate, colon, lung, pancreatic, liver and breast cancers, among others. It has not yet been approved in the United States.

Daniels decided to travel to Mexico for two weeks of SPDT treatment followed by a two month home program. "My doctors were not opposed to this," Daniels says. "They had nothing left to offer me."

"From the minute I walked into this clinic I had hope." Daniels says the doctors were upbeat and the staff was exceptionally caring. "The treatment was painless and there were no side effects. When I finished the program, my CAT scans were absolutely clear and my blood work was normal. I continue to have testing done every few months, and I am still completely cancer free. I stay on a maintenance program. I am going to watch my daughter grow up. I married my long time sweetheart. I only wish I would have found this treatment sooner."

Marla Manhart is a health writer and patient advocate. She can be reached at: mkmsrq@gmail.com


'/>"/>
SOURCE TMD Limited Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Positive CHMP Opinion for JAVLOR(R) in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum-Containing Regimen
2. Botox injections can significantly improve quality of life for people with overactive bladders
3. Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
4. Study Cites Gains in Gall Bladder Cancer Treatment
5. Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction
6. New Data Presented at AUAs Annual Conference Prove GELNIQUE(TM) (oxybutynin chloride) 10% gel is an Effective, Safe Option for Female Overactive Bladder (OAB) Patients
7. Mayo Clinic researcher says improved detection of bladder tumors reduces cancer recurrence
8. Genetic analysis may predict risk of invasive bladder cancer
9. Genetic variants predict recurrence of bladder cancer, patient survival
10. Know Your Bladder Better
11. More intensive treatment not associated with better outcomes in early bladder cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... The Gallery ... Kevin Sadati, is pleased to announce a new treatment option called Vivace Microneedling. ... their face, neck, and body through a virtually pain-free, non-surgical treatment. Vivace Microneedling ...
(Date:5/23/2017)... ... May 23, 2017 , ... New patients from Charleston, SC, are ... dentist practicing in Mt. Pleasant, SC, with or without a referral. A full mouth ... with missing teeth in Charleston, SC. Those who suffer from gum disease, ...
(Date:5/23/2017)... WI (PRWEB) , ... May 23, 2017 , ... Patients ... to call Dr. Angela Cotey’s practice to schedule an appointment, with or without a ... and frequently offers pulpotomy treatments to pediatric patients as a healthy alternative to a ...
(Date:5/22/2017)... PA (PRWEB) , ... May 22, 2017 , ... An ... to write with a pen. "My wife’s hand was damaged in a firework accident, ... something that helps people with manual problems." , He then designed and created a ...
(Date:5/22/2017)... ... May 22, 2017 , ... ... larger group investing in InsightRX, an early stage company in San Francisco that ... pharmacological characteristics. Greatpoint Ventures Innovation Fund acted as the lead investor ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/10/2017)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... quarter ended April 1, 2017 .   GAAP diluted ... to the prior year period as the sale of ... while non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue ... currency terms.  Excluding the effects of blood screening and ...
Breaking Medicine Technology: